Bright Green Corporation Merges with PharmAGRI Capital Partners; Lynn Stockwell Appointed CEO and Chairwoman
Tesla Robotics to Power Sovereign “Seed to Syringe” Pharmaceutical Infrastructure Fort Lauderdale,…
Ryan Group of Schools’ INMUN 2025: Young Leaders Unite to Shape the Future
NEW DELHI, Sept. 6, 2025 /PRNewswire/ -- More than 1,200 students from over…
Coventry and Alan Buerger Move to Dismiss Abacus Lawsuit
Motion underscores that Abacus's claims lack merit as Lapetus, its key life…
Actuate Therapeutics Presents Topline Elraglusib Phase 2 Data at ASCO 2025 Annual Meeting: Trial Meets Primary Endpoint of Median Overall Survival and Doubles 1-Year Survival in First-Line Treatment of Metastatic Pancreatic Cancer
Phase 2 (Actuate-1801 Part 3B) trial meets primary endpoint and demonstrates a…